Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Halahleh Khalid

High-Dose Therapy and Autologous Hematopoietic Progenitor Cells Transplantation for Relapsed or Refractory Hodgkin Lymphoma: A Follow Up Analysis of King Hussein Cancer Center,results and Prognostic Variables

Trends in Transplantation

2018

English

Related publications

Brentuximab Vedotin Salvage Followed by Consolidation Post Autologous Hematopoietic Stem Cell Transplantation in High Risk Relapsed Refractory Hodgkin Lymphoma

Hematological Oncology

English

Timing of Salvage Therapy and Autologous Hematopoietic Cell Transplant in Relapsed Hodgkin and Non Hodgkin Lymphoma

Biology of Blood and Marrow Transplantation

Transplantation

Hematology

2016

English

A Phase I Trial of 19-28z Car-T Cells Post-High Dose Therapy and Autologous Transplantation (Hdt-Asct) for Relapsed and Refractory (R/R) B-Cell Non-Hodgkin Lymphoma (B-Nhl)

Hematological Oncology

English

Prognostic Value of Pretransplant FDG-PET in Refractory/Relapsed Hodgkin Lymphoma Treated With Autologous Stem Cell Transplantation: Systematic Review and Meta-Analysis

English

Nivolumab for Relapsed/Refractory Classical Hodgkin Lymphoma After Autologous Transplant: Full Results After Extended Follow-Up of the Phase 2 Checkmate 205 Trial

Hematological Oncology

English

Prognostic Factors and Long-Term Outcome of Autologous Haematopoietic Stem Cell Transplantation Following a Uniform-Modified BEAM-conditioning Regimen for Patients With Refractory or Relapsed Hodgkin Lymphoma: A Single-Center Experience

English

Haploidentical Hematopoietic Stem Cell Transplantation Compared With Hla-Matched Stem Cell Transplantation for Refractory or Relapsed Aggressive Non-Hodgkin Lymphoma

Hematological Oncology

English

High-Dose Chemotherapy (HDC) and Autologous Hematopoietic Stem Cell Transplantation (ASCT) as Salvage Therapy for Relapsed Osteosarcoma

Bone Marrow Transplantation

Transplantation

Hematology

2001

English

Relapsed and Refractory Nodular Lymphocyte-Predominant Hodgkin Lymphoma (Nlphl): A Us Analysis From Md Anderson Cancer Center

Hematological Oncology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Halahleh Khalid

High-Dose Therapy and Autologous Hematopoietic Progenitor Cells Transplantation for Relapsed or Refractory Hodgkin Lymphoma: A Follow Up Analysis of King Hussein Cancer Center,results and Prognostic Variables

Related publications

Brentuximab Vedotin Salvage Followed by Consolidation Post Autologous Hematopoietic Stem Cell Transplantation in High Risk Relapsed Refractory Hodgkin Lymphoma

Timing of Salvage Therapy and Autologous Hematopoietic Cell Transplant in Relapsed Hodgkin and Non Hodgkin Lymphoma

A Phase I Trial of 19-28z Car-T Cells Post-High Dose Therapy and Autologous Transplantation (Hdt-Asct) for Relapsed and Refractory (R/R) B-Cell Non-Hodgkin Lymphoma (B-Nhl)

Prognostic Value of Pretransplant FDG-PET in Refractory/Relapsed Hodgkin Lymphoma Treated With Autologous Stem Cell Transplantation: Systematic Review and Meta-Analysis

Nivolumab for Relapsed/Refractory Classical Hodgkin Lymphoma After Autologous Transplant: Full Results After Extended Follow-Up of the Phase 2 Checkmate 205 Trial

Prognostic Factors and Long-Term Outcome of Autologous Haematopoietic Stem Cell Transplantation Following a Uniform-Modified BEAM-conditioning Regimen for Patients With Refractory or Relapsed Hodgkin Lymphoma: A Single-Center Experience

Haploidentical Hematopoietic Stem Cell Transplantation Compared With Hla-Matched Stem Cell Transplantation for Refractory or Relapsed Aggressive Non-Hodgkin Lymphoma

High-Dose Chemotherapy (HDC) and Autologous Hematopoietic Stem Cell Transplantation (ASCT) as Salvage Therapy for Relapsed Osteosarcoma

Relapsed and Refractory Nodular Lymphocyte-Predominant Hodgkin Lymphoma (Nlphl): A Us Analysis From Md Anderson Cancer Center